TECH Bio-Techne

  • Official Name: BIO-TECHNE CORPORATION
  • Headquarters: 614 MCKINLEY PL N E, MINNEAPOLIS, MN, 55413 US
  • CEO: Kim Kelderman
  • Website: bio-techne.com

Match Results

Date League Week Opponent Result Score
2025-07-15 1R Lost by 2.161 (1.498) - 0.663
2025-07-16 1R Lost by 1.383 0.703 - 2.086
2025-07-18 1 Lost by 2.251 (4.932) - (2.681)
2025-07-25 2 Won by 7.525 TOTW 11.296 - 3.771
2025-08-01 3 Won by 0.627 (4.662) - (5.289)
2025-08-07 1R Won by 4.503 2.266 - (2.237)
2025-08-08 4 Lost by 6.767 (4.133) - 2.634
2025-08-15 5 Won by 3.906 TOTW 5.310 - 1.404
2025-08-21 2R Lost by 1.773 (0.238) - 1.535
2025-08-22 6 Won by 2.173 5.388 - 3.215
2025-08-29 7 Lost by 5.352 (4.420) - 0.932
2025-09-05 8 Lost by 0.605 (0.413) - 0.192
2025-09-12 9 Lost by 5.612 (6.220) - (0.608)
2025-09-19 10 Won by 4.669 3.633 - (1.036)
2025-09-26 11 Won by 1.672 (2.142) - (3.814)
2025-10-03 12 Won by 18.627 TOTW 17.063 - (1.564)
2025-10-10 13 Lost by 2.770 (6.781) - (4.011)
2025-10-17 14 Won by 7.619 5.737 - (1.882)
2025-10-24 15 Won by 4.060 TOTW 6.747 - 2.687

Latest News

Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package
Yahoo - 2026-09-25

Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package 🔗

Bio-Techne Corporation (NASDAQ:TECH) shareholders voted on September 23 to approve the company’s acquisition by Merck KGaA of Darmstadt, Germany. Th...

Robert V Baumgartner Exercises Options, Realizes $754K
Benzinga - 2026-09-25

Robert V Baumgartner Exercises Options, Realizes $754K 🔗

Robert V Baumgartner, Board Member at Bio-Techne (NASDAQ:TECH), reported a large exercise of company stock options on September 24, according to a new...

Is Bio-Techne Stock Outperforming the Nasdaq?
Yahoo - 2026-09-24

Is Bio-Techne Stock Outperforming the Nasdaq? 🔗

Bio-Techne has outperformed the Nasdaq over the past year, but analysts are cautious about the stock’s prospects.

3 Reasons to Sell TECH and 1 Stock to Buy Instead
Yahoo - 2026-09-23

3 Reasons to Sell TECH and 1 Stock to Buy Instead 🔗

Bio-Techne has had an impressive run over the past six months as its shares have beaten the S&P 500 by 21.5%. The stock now trades at $72.56, mark...

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
Yahoo - 2026-09-23

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany 🔗

Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced t...

Show more
SeekingAlpha - 2026-07-13

Revvity: Overvalued On Sentiment 🔗